Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2022 Earnings Call Transcript

Joy Zhang: That’s super, super helpful. Thank you. And as a follow-up, maybe I’ll just tag on another gross margin question. Can you update us on, sort of what percentage of your prescription volume today is done through the in-house fulfillment centers? And how much juice is there left to squeeze in terms of margin benefits from that going forward?

Andrew Dudum: Yes, it’s a great question. I think we disclosed in the latest presentation that’s north of 55% of the business is being fulfilled through the affiliated pharmacies. And so, there’s still quite a bit left to go, which is great, and there are quite a bit of opportunities to streamline the margin profile and the efficiency of that remaining percentage. And so, improving quite a bit, but still quite a lot of opportunity on the horizon for us to drive efficiency.

Joy Zhang: Alright. Thank you.

Andrew Dudum: Thank you.

Operator: Thank you. And ladies and gentlemen, that will conclude our question-and-answer session today, as well as bring us to the end of today’s conference call. Again, we’d like to thank you all so much for joining the Hims & Hers Health fourth quarter 2022 earnings conference call and wish you all a great remainder of your day. Goodbye.